DOCSLIB.ORG

REVIEW J Am Soc Nephrol 12: 2181–2189, 2001

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
REVIEW J Am Soc Nephrol 12: 2181–2189, 2001 REVIEW J Am Soc Nephrol 12: 2181–2189, 2001 The Kidney and Homocysteine Metabolism ALLON N. FRIEDMAN,*† ANDREW G. BOSTOM,*‡ JACOB SELHUB,* ANDREW S. LEVEY,† and IRWIN H. ROSENBERG* *Vitamin Metabolism and Aging, Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts; †Division of Nephrology, Tufts University-New England Medical Center, Boston, Massachusetts; and ‡Division of General Internal Medicine, Memorial Hospital of Rhode Island, Pawtucket, Rhode Island. Abstract. Homocysteine (Hcy) is an intermediate of methio- renal Hcy handling and should be considered when measuring nine metabolism that, at elevated levels, is an independent risk Hcy plasma flux and renal clearance. The underlying cause of factor for vascular disease and atherothrombosis. Patients with hyperhomocysteinemia in renal disease is not entirely under- renal disease, who exhibit unusually high rates of cardiovas- stood but seems to involve reduced clearance of plasma Hcy. cular morbidity and death, tend to be hyperhomocysteinemic, This reduction may be attributable to defective renal clearance particularly as renal function declines. This observation and the and/or extrarenal clearance and metabolism, the latter possibly inverse relationship between Hcy levels and GFR implicate the resulting from retained uremic inhibitory substances. Although kidney as an important participant in Hcy handling. The nor- the currently available evidence is not conclusive, it seems mal kidney plays a major role in plasma amino acid clearance more likely that a reduction in renal Hcy clearance and me- and metabolism. The existence in the kidney of specific Hcy tabolism is the cause of the hyperhomocysteinemic state. Ef- uptake mechanisms and Hcy-metabolizing enzymes suggests forts to resolve this important issue will advance the search for that this role extends to Hcy. Dietary protein intake may affect effective Hcy-lowering therapies in patients with renal disease. Homocysteine (Hcy) is an amino acid metabolite that has been introduces the issues of Hcy plasma flux, protein binding, and implicated, in retrospective and prospective studies, as a potential general metabolism, and reviews amino acid/Hcy metabolism in atherogenic agent and risk factor for cardiovascular disease normal kidneys, including the effects of dietary intake on this (CVD) (1–3). Hyperhomocysteinemia, the state of elevated process. It then reviews the association between Hcy and the plasma Hcy levels, is very common among patients with chronic GFR, amino acid/Hcy metabolism in diseased kidneys, and in- renal insufficiency (defined as the range of kidney function below sights gleaned from Hcy-lowering trials. It concludes with the normal but above that requiring renal replacement therapy) and hypothesis that the hyperhomocysteinemia of renal disease is occurs almost uniformly in the end-stage renal disease (ESRD) primarily attributable to reduced renal clearance and intrarenal population (4). This is of particular importance for the latter group metabolism. of patients, in which CVD is the major cause of death. In fact, these patients may have up to a 30 times higher risk of CVD- related death than the general population (5). Interestingly, tradi- Plasma Hcy Levels, Protein Binding, and Flux tional cardiac risk factors may not be able to account for this high Average fasting plasma total Hcy levels for healthy human mortality rate (6). Despite the abundance of data on Hcy metab- subjects in the current era of flour and grain folic acid fortifi- olism, the pathogenesis of hyperhomocysteinemia in renal disease cation range between 6 and 12 ␮M (Table 1) (7), with “mod- remains unclear. A better understanding of this deranged state erate” hyperhomocysteinemia occurring when levels are be- would advance current knowledge of renal physiologic processes, tween 12 and 30 ␮M, “intermediate” hyperhomocysteinemia as well as efforts to find an effective therapy. Although there is occurring when levels are between 31 and 100 ␮M, and “se- abundant evidence suggesting that the kidney plays a prominent vere” hyperhomocysteinemia occurring when levels are greater role in Hcy metabolism, there is considerable controversy sur- than 100 ␮M (8). In normal subjects, approximately 75% of rounding the extent and mechanisms of this role. This article total plasma Hcy is bound via a disulfide bond, to protein, primarily albumin, [bound Hcy (bHcy)], while the remaining 25% exists in a free unbound form [free Hcy (fHcy)] (Figure 1) Received January 24, 2001. Accepted March 24, 2001. (9,10). fHcy is composed almost entirely of oxidized, disul- Correspondence to Dr. Allon N. Friedman, Vitamin Metabolism and Aging, fide-linked heterodimers (Hcy-cysteine) or homodimers (Hcy- Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts Hcy, or homocystine), with perhaps 1 to 2% existing in a University, 711 Washington Street, Room 829, Boston, MA 02111. Phone: 617-556-3007; Fax: 617-556-3166; E-mail: [email protected] reduced sulfhydryl state (11). Unfortunately, fHcy is inherently 1046-6673/1210-2181 unstable, and accurate levels may be difficult to measure. Of Journal of the American Society of Nephrology importance, only the fHcy fraction is thought to be freely Copyright © 2001 by the American Society of Nephrology filtered at the glomerulus. The fHcy/bHcy ratio varies among 2182 Journal of the American Society of Nephrology J Am Soc Nephrol 12: 2181–2189, 2001 Table 1. Comparison of ranges of total Hcy levels in different populationsa Geometric Means 10th to 90th Percentile Group (␮M) Total Hcy Levels (␮M) End-stage renal disease 24 12 to 39 Renal transplantationb 15 9to25 Chronic renal insufficiencyb 15 9to25 Normal renal function (population-based controls)c 9 6 to 12 a Hcy, homocysteine. Modified from reference 7, with permission. b Renal transplant recipients receiving standard immunosuppressive therapy and patients with chronic renal insufficiency receiving no immunosuppressive drugs, with equivalent renal function. c In the current era of folic acid-fortified cereal grain flour. species. For example, in contrast to humans, approximately 65 Hyperhomocysteinemia is a condition in which the regula- to 75% of Hcy in rats is in the free form (12). tion of intracellular Hcy levels is disrupted and Hcy export to Hcy production occurs in all cells as a consequence of the the plasma compartment is accelerated and/or normal Hcy normal methylation process (Figure 2). The Hcy volume of dis- plasma clearance is decreased. Human kinetic studies suggest tribution in healthy subjects was observed to be approximately 0.4 that hyperhomocysteinemia in those with vitamin B12 or folate L/kg, similar to that in subjects with severe renal insufficiency deficiency is caused by enhanced tissue export of Hcy (19). In (13). Intracellular Hcy levels rise with enhanced intracellular Hcy contrast, hyperhomocysteinemia in renal disease is related to production and/or inhibition of intracellular metabolism. To main- reduced plasma Hcy clearance (13). The underlying cause of tain low intracellular levels of this putatively cytotoxic substance, this reduction is unknown but involves a defect in renal and/or Hcy that is not metabolized within the cell is exported to the extrarenal clearance. As noted below, the kidney likely plays plasma compartment (14,15). Calculations based on steady-state an important role in Hcy clearance and metabolism. kinetics in healthy adult humans estimate that 1.2 mmol of Hcy, or approximately 5 to 10% of the total daily cellular production, General Metabolism is delivered daily to the plasma compartment (16,17). Because Hcy is an endogenous sulfur-containing amino acid inter- Hcy is constantly produced and exported by cells, it must also be mediate of the essential amino acid methionine and is not constantly cleared for plasma levels to remain within 10% of obtained from the diet. An overview of the metabolic pathway baseline values, as they do in healthy human subjects (18). Plasma is presented in Figure 2. Methionine enters the one-carbon Hcy levels are not known to be actively regulated. metabolic cycle either through the dietary consumption of Figure 1. Homocysteine (Hcy) and the major related disulfides in normal human plasma. Reprinted from reference 9, with permission. J Am Soc Nephrol 12: 2181–2189, 2001 The Kidney and Hcy Metabolism 2183 Figure 2. Hcy metabolism. Enzyme reactions that are regulated by S-adenosylmethionine (SAM) and 5-methyltetrahydrofolate (MethylTHF) are indicated by large arrows. Open arrows indicate activation, and closed arrows indicate inhibition. Enzymes are as follows: 1, 5,10- methylenetetrahydrofolate reductase; 2, methionine synthase; 3, S-adenosylmethionine synthase; 4, S-adenosylhomocysteine hydrolase; 5, cystathionine ␤-synthase; 6, betaine/Hcy methyltransferase; 7, glycine N-methyltransferase; 8, serine hydroxymethyltransferase; 9, cystathio- nase. THF, tetrahydrofolate; FAD, flavin adenine dinucleotide; PLP, pyridoxal-5-phosphate. Modified from reference 4, with permission. methionine-containing protein or through endogenous protein Folate or B vitamin deficiencies and inborn errors of me- breakdown. It is then converted intracellularly to S-adenosyl- tabolism are well recognized causes of hyperhomocysteinemia methionine, which functions as a universal methyl donor for a (14). Folate and vitamin B12 deficiencies cause fasting Hcy variety of important acceptors, including nucleic acids, neuro-
Load more

Recommended publications
  • S41598-021-96252-4.Pdf
    www.nature.com/scientificreports OPEN Comprehensive polar metabolomics and lipidomics profling discriminates the transformed from the non‑transformed state in colon tissue and cell lines Caroline Rombouts1,2,3, Margot De Spiegeleer1, Lieven Van Meulebroek1, Lynn Vanhaecke1,4,5* & Winnok H. De Vos3,5* Colorectal cancer (CRC) is the fourth most lethal disease worldwide. Despite an urgent need for therapeutic advance, selective target identifcation in a preclinical phase is hampered by molecular and metabolic variations between cellular models. To foster optimal model selection from a translational perspective, we performed untargeted ultra‑high performance liquid chromatography coupled to high‑resolution mass spectrometry‑based polar metabolomics and lipidomics to non‑ transformed (CCD841‑CON and FHC) and transformed (HCT116, HT29, Caco2, SW480 and SW948) colon cell lines as well as tissue samples from ten colorectal cancer patients. This unveiled metabolic signatures discriminating the transformed from the non‑transformed state. Metabolites involved in glutaminolysis, tryptophan catabolism, pyrimidine, lipid and carnitine synthesis were elevated in transformed cells and cancerous tissue, whereas those involved in the glycerol‑3‑phosphate shuttle, urea cycle and redox reactions were lowered. The degree of glutaminolysis and lipid synthesis was specifc to the colon cancer cell line at hand. Thus, our study exposed pathways that are specifcally associated with the transformation state and revealed diferences between colon cancer cell lines that should be considered when targeting cancer‑associated pathways. Colorectal cancer (CRC) is the second and third most diagnosed cancer in females and males, respectively, and the fourth leading cause of cancer-related mortality worldwide. Te incidence rates are strongly variable throughout the world, whereby developed regions have more CRC patients than less developed countries.
    [Show full text]
  • Cysteine Dioxygenase 1 Is a Metabolic Liability for Non-Small Cell Lung Cancer Authors: Yun Pyo Kang1, Laura Torrente1, Min Liu2, John M
    bioRxiv preprint doi: https://doi.org/10.1101/459602; this version posted November 1, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer Authors: Yun Pyo Kang1, Laura Torrente1, Min Liu2, John M. Asara3,4, Christian C. Dibble5,6 and Gina M. DeNicola1,* Affiliations: 1 Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA 2 Proteomics and Metabolomics Core Facility, Moffitt Cancer Center and Research Institute, Tampa, FL, USA 3 Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA, USA 4 Department of Medicine, Harvard Medical School, Boston, MA, USA 5 Department of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA 6 Department of Pathology, Harvard Medical School, Boston, MA, USA *Correspondence to: [email protected]. Keywords: KEAP1, NRF2, cysteine, CDO1, sulfite Summary NRF2 is emerging as a major regulator of cellular metabolism. However, most studies have been performed in cancer cells, where co-occurring mutations and tumor selective pressures complicate the influence of NRF2 on metabolism. Here we use genetically engineered, non-transformed primary cells to isolate the most immediate effects of NRF2 on cellular metabolism. We find that NRF2 promotes the accumulation of intracellular cysteine and engages the cysteine homeostatic control mechanism mediated by cysteine dioxygenase 1 (CDO1), which catalyzes the irreversible metabolism of cysteine to cysteine sulfinic acid (CSA). Notably, CDO1 is preferentially silenced by promoter methylation in non-small cell lung cancers (NSCLC) harboring mutations in KEAP1, the negative regulator of NRF2.
    [Show full text]
  • Methionine + Cystine Levels and Vitamin B6 Supplementation on Performance and Enzyme Expression of Methionine Metabolism of Gilts from 75 to 100 Kg
    Revista Brasileira de Zootecnia Brazilian Journal of Animal Science © 2017 Sociedade Brasileira de Zootecnia ISSN 1806-9290 R. Bras. Zootec., 46(3):223-230, 2017 www.sbz.org.br Methionine + cystine levels and vitamin B6 supplementation on performance and enzyme expression of methionine metabolism of gilts from 75 to 100 kg Cleiton Pagliari Sangali1*, Eliane Gasparino2, Ricardo Souza Vasconcellos2, Marcelise Regina Fachinello1, Alessandra Nardina Trícia Rigo Monteiro1, Lucas Antonio Costa Esteves1, Lucas Pimentel Bonagurio1, Paulo Cesar Pozza2 1 Universidade Estadual de Maringá, Programa de Pós-graduação em Zootecnia, Maringá, PR, Brazil. 2 Universidade Estadual de Maringá, Departamento de Zootecnia, Maringá, PR, Brazil. ABSTRACT - This study was carried out to evaluate the effect of different levels of standardized ileal digestible (SID) methionine + cystine (Met+Cys) and vitamin B6 supplementation on the performance, blood variables, and gene expression of enzymes involved in methionine metabolism in female pigs between 75 and 100 kg. Fifty six female pigs were used (Talent × Topigs 20), averaging 75.06±1.68 kg in initial weight, allotted in a completely randomized block design arranged in a 2 × 4 factorial scheme, composed of two vitamin B6 supplementation levels (1.58 and 3.58 mg/kg) and four levels of SID Met+Cys (0.370, 0.470, 0.570, and 0.670%), with seven replicates and one animal per experimental unit. No interactions between vitamin B6 supplementation and SID Met+Cys levels were observed. The levels of SID Met+Cys and vitamin B6 supplementation did not affect animal performance. Triacylglycerols showed a quadratic response to the SID Met+Cys levels, in which the lowest plasma concentration was estimated as 0.575%.
    [Show full text]
  • Supplementary Data
    Metabolomics in cancer research: Supplementary data 1 Supplementary Data 2 Supplementary methods 3 Additional information regarding the search strategy used in the main paper 4 Supplementary tables 5 Supplementary Table 1: List of reported metabolites to be altered in human cancers 6 Supplementary figures 7 Supplementary Figure 1: General overview over the metabolomics workflow 8 1 Metabolomics in cancer research: Supplementary data 9 Supplementary methods 10 Search strategy 11 The search strategy was described in the main paper. For the Web of Knowledge search an 12 additional refinement step was necessary to reduce irrelevant findings. The following research 13 areas of low relevance were excluded: 14 Plant Science, Biophysics, Agriculture, Environmental Sciences Ecology, Microbiology, 15 Computer Science, Mathematics, Cardiology, Engineering, Automation control Systems, 16 Marine Freshwater Biology, Behavioral Science, Physics, Developmental Biology, Zoology, 17 Psychiatry, Energy Fuels, Infectious Disease, Parasitology, Mycology, Rheumatology, 18 Psychology, Veterinary Sciences, Dentistry, Legal Medicine, Polymer Science, 19 Anesthesiology, Robotics, Sports Science, Forestry, Tropical Medicine, Virology, Water 20 Resources, Electrochemistry, Evolutionary Biology, Fisheries, Materials Science, 21 Oceanography, Substance Abuse, Geology, Nuclear Science Technology, Operations 22 Research Management, Orthopedics, Allergy, Biodiversity, Educational Research, 23 Metallurgy, Optics, Emergency Medicine, Geochemistry, History philosophy of science, 24 Mathematical methods in Social sciences, Mechanics, Social Issues, Thermodynamics 25 Additionally the abstracts had to contain one of the following keywords: 26 “MS” OR “mass spectrometry” OR “patients”. 2 Metabolomics in cancer research: Supplementary data 27 Supplementary tables 28 Supplementary Table 1: List of reported metabolites altered in human cancers. Metabolites in bold were reported from a study that validated 29 findings within an independent study population.
    [Show full text]
  • Serum Metabolite Profiles As Potential Biochemical Markers in Young
    www.nature.com/scientificreports OPEN Serum metabolite profles as potential biochemical markers in young adults with community- acquired pneumonia cured by moxifoxacin therapy Bo Zhou1, Bowen Lou2,4, Junhui Liu3* & Jianqing She2,4* Despite the utilization of various biochemical markers and probability calculation algorithms based on clinical studies of community-acquired pneumonia (CAP), more specifc and practical biochemical markers remain to be found for improved diagnosis and prognosis. In this study, we aimed to detect the alteration of metabolite profles, explore the correlation between serum metabolites and infammatory markers, and seek potential biomarkers for young adults with CAP. 13 Eligible young mild CAP patients between the ages of 18 and 30 years old with CURB65 = 0 admitted to the respiratory medical department were enrolled, along with 36 healthy participants as control. Untargeted metabolomics profling was performed and metabolites including alcohols, amino acids, carbohydrates, fatty acids, etc. were detected. A total of 227 serum metabolites were detected. L-Alanine, 2-Hydroxybutyric acid, Methylcysteine, L-Phenylalanine, Aminoadipic acid, L-Tryptophan, Rhamnose, Palmitoleic acid, Decanoylcarnitine, 2-Hydroxy-3-methylbutyric acid and Oxoglutaric acid were found to be signifcantly altered, which were enriched mainly in propanoate and tryptophan metabolism, as well as antibiotic-associated pathways. Aminoadipic acid was found to be signifcantly correlated with CRP levels and 2-Hydroxy-3-methylbutyric acid and Palmitoleic acid with PCT levels. The top 3 metabolites of diagnostic values are 2-Hydroxybutyric acid(AUC = 0.90), Methylcysteine(AUC = 0.85), and L-Alanine(AUC = 0.84). The AUC for CRP and PCT are 0.93 and 0.91 respectively.
    [Show full text]
  • Title: Lysosomal Cystine Mobilization Shapes the Response of Mtorc1 and Tissue Growth to Fasting
    bioRxiv preprint doi: https://doi.org/10.1101/606541; this version posted May 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Title: Lysosomal cystine mobilization shapes the response of mTORC1 and tissue growth to fasting. Authors: Patrick Jouandin1†*, Zvonimir Marelja2,3†, Andrey A Parkhitko1, Miriam Dambowsky2, John M Asara4,5, Ivan Nemazanyy6, Christian C. Dibble7,8, Matias Simons2,3§* and Norbert Perrimon1,9§* Affiliations: 1Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA 2 Laboratory of Epithelial Biology and Disease, Imagine Institute, Université Paris-Descartes- Sorbonne Paris Cité, 75015 Paris, France 3 Institute of Human Genetics, University Hospital Heidelberg, 69120 Heidelberg, Germany 4Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA 5Department of Medicine, Harvard Medical School, Boston, MA 02175, USA 6Platform for Metabolic Analyses, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS 3633, 160 rue de Vaugirard, Paris, 75015, France 7Department of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, United States 8Department of Pathology, Harvard Medical School, Boston, United States 9Howard Hughes Medical Institute, Harvard Medical School, Boston, MA, 02115, USA *Correspondence to: [email protected]; [email protected]; [email protected]. †These authors contributed equally to this work §These authors contributed equally to this work Abstract: Adaptation to nutrient scarcity involves an orchestrated response of metabolic and signaling pathways to maintain homeostasis. We provide evidence that lysosomal export of cystine coordinates remobilization of internal nutrient stores with reactivation of the growth regulator TORC1 signaling upon fasting in the Drosophila fat body.
    [Show full text]
  • Defective Homocysteine Metabolism: Potential Implications for Skeletal Muscle Malfunction
    Int. J. Mol. Sci. 2013, 14, 15074-15091; doi:10.3390/ijms140715074 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review Defective Homocysteine Metabolism: Potential Implications for Skeletal Muscle Malfunction Sudhakar Veeranki * and Suresh C. Tyagi * Department of Physiology and Biophysics, University of Louisville School of Medicine, Louisville, KY 40202, USA * Authors to whom correspondence should be addressed; E-Mails: [email protected] (S.V.); [email protected] (S.C.T.); Tel.: +1-973-610-1160 (S.V.); +1-502-852-3381 (S.C.T.); Fax: +1-502-852-6239 (S.C.T.). Received: 27 May 2013; in revised form: 24 June 2013 / Accepted: 11 July 2013 / Published: 18 July 2013 Abstract: Hyperhomocysteinemia (HHcy) is a systemic medical condition and has been attributed to multi-organ pathologies. Genetic, nutritional, hormonal, age and gender differences are involved in abnormal homocysteine (Hcy) metabolism that produces HHcy. Homocysteine is an intermediate for many key processes such as cellular methylation and cellular antioxidant potential and imbalances in Hcy production and/or catabolism impacts gene expression and cell signaling including GPCR signaling. Furthermore, HHcy might damage the vagus nerve and superior cervical ganglion and affects various GPCR functions; therefore it can impair both the parasympathetic and sympathetic regulation in the blood vessels of skeletal muscle and affect long-term muscle function. Understanding cellular targets of Hcy during HHcy in different contexts and its role either as a primary risk factor or as an aggravator of certain disease conditions would provide better interventions. In this review we have provided recent Hcy mediated mechanistic insights into different diseases and presented potential implications in the context of reduced muscle function and integrity.
    [Show full text]
  • Cysteine Catabolism: a Novel Metabolic Pathway Contributing to Glioblastoma Growth
    Published OnlineFirst December 18, 2013; DOI: 10.1158/0008-5472.CAN-13-1423 Cancer Molecular and Cellular Pathobiology Research Cysteine Catabolism: A Novel Metabolic Pathway Contributing to Glioblastoma Growth Antony Prabhu1,2, Bhaswati Sarcar1,2, Soumen Kahali1,2, Zhigang Yuan2, Joseph J. Johnson3, Klaus-Peter Adam5, Elizabeth Kensicki5, and Prakash Chinnaiyan1,2,4 Abstract The relevance of cysteine metabolism in cancer has gained considerable interest in recent years, largely focusing on its role in generating the antioxidant glutathione. Through metabolomic profiling using a combination of high-throughput liquid and gas chromatography–based mass spectrometry on a total of 69 patient-derived glioma specimens, this report documents the discovery of a parallel pathway involving cysteine catabolism that results in the accumulation of cysteine sulfinic acid (CSA) in glioblastoma. These studies identified CSA to rank as one of the top metabolites differentiating glioblastoma from low-grade glioma. There was strong intratumoral concordance of CSA levels with expression of its biosynthetic enzyme cysteine dioxygenase 1 (CDO1). Studies designed to determine the biologic consequence of this metabolic pathway identified its capacity to inhibit oxidative phosphorylation in glioblastoma cells, which was determined by decreased cellular respiration, decreased ATP production, and increased mitochondrial membrane potential following pathway activation. CSA-induced attenuation of oxidative phosphorylation was attributed to inhibition of the regulatory enzyme pyruvate dehydrogenase. Studies performed in vivo abrogating the CDO1/CSA axis using a lentiviral-mediated short hairpin RNA approach resulted in significant tumor growth inhibition in a glioblastoma mouse model, supporting the potential for this metabolic pathway to serve as a therapeutic target. Collectively, we identified a novel, targetable metabolic pathway involving cysteine catabolism contributing to the growth of aggressive high-grade gliomas.
    [Show full text]
  • The Efficiency of Enzymatic L-Cysteine Oxidation in Mammalian Systems Derives from the Optimal Organization of the Active Site of Cysteine Dioxygenase
    The Efficiency of Enzymatic L-Cysteine Oxidation in Mammalian Systems Derives from the Optimal Organization of the Active Site of Cysteine Dioxygenase by Catherine Wangui Njeri A dissertation submitted to the Graduate Faculty of Auburn University in partial fulfillment of the requirements for the Degree of Doctor of Philosophy Auburn, Alabama May 4, 2014 Copyright 2014 by Catherine Wangui Njeri Approved by Holly R. Ellis, Chair, Associate Professor of Chemistry and Biochemistry Douglas C. Goodwin, Associate professor of Chemistry and Biochemistry Evert E. Duin, Associate Professor of Chemistry and Biochemistry Paul A. Cobine, Assistant Professor of Biological Sciences Benson T. Akingbemi, Associate Professor of Anatomy Abstract Intracellular concentrations of free cysteine in mammalian organisms are maintained within a healthy equilibrium by the mononuclear iron-dependent enzyme, cysteine dioxygenase (CDO). CDO catalyzes the oxidation of L-cysteine to L-cysteine sulfinic acid (L-CSA), by incorporating both atoms of molecular oxygen into the thiol group of L-cysteine. The product of this reaction, L-cysteine sulfinic acid, lies at a metabolic branch-point that leads to the formation of pyruvate and sulfate or taurine. The available three-dimensional structures of CDO have revealed the presence of two very interesting features within the active site (1-3). First, in close proximity to the active site iron, is a covalent crosslink between Cys93 and Tyr157. The functions of this structure and the factors that lead to its biogenesis in CDO have been a subject of vigorous investigation. Purified recombinant CDO exists as a mixture of the crosslinked and non crosslinked isoforms, and previous studies of CDO have involved a heterogenous mixture of the two.
    [Show full text]
  • Plasma Methylation Profile RESOURCE GUIDE
    Plasma Methylation Profile RESOURCE GUIDE Science + Insight doctorsdata.com Methionine SAMe DNA SHMT THF RNA 5, 10 Methyltransferases MethyleneTHF Protein Thymidine DMG Lipids synthesis B12 BHMT SAH dUMP MTRR MTR TMG adenosine AHCY MTHFR Homocysteine 5 Methyl THF CBS Cystathionine Cysteine Sulte SUOX Sulfate Introduction The Plasma Methylation Profile is a functional assessment of the enzymes involved in methionine metabolism and the trans-sulfuration pathway (commonly called the “Methylation Pathway”). The genomics revolution has made it possible to assess genetic information stored in the DNA code. An awareness of single nucleotide polymorphisms (SNPs) has made genetic testing for certain SNPs part of diagnostic patient assessment. While the identification of SNPs in a patient’s genome is important, it is vital to remember that functional testing of enzymes should determine treatment decisions. There are many layers of translation between the genome and the enzyme. Enzyme function may be compromised not only by inheritance, but also by acquired epigenetic factors such as nutritional status, oxidative stress, autoimmunity or environmental exposures. There is mounting evidence that, especially within the folate and methylation pathways, multiple SNPs in multiple genes (haplotypes) may be necessary to alter metabolism or change health outcomes. Gastrointestinal functions may influence absorption, physiology, metabolism and immunity; nutrient maldigestion or malabsorption may inhibit normal enzyme functions, and may have greater effects on enzymes with SNPs. © 2016 Doctor’s Data, Inc. All rights reserved. doctorsdata.com Doctor’s Data, Inc. Plasma Methylation Enzyme and Nutrition Guide 2 Methionine High Methionine may be elevated for a variety of reasons. Several enzymes involved in the metabolism of methionine require magnesium and other nutritional cofactors.
    [Show full text]
  • Genome-Scale Metabolic Network Analysis and Drug Targeting of Multi-Drug Resistant Pathogen Acinetobacter Baumannii AYE
    Electronic Supplementary Material (ESI) for Molecular BioSystems. This journal is © The Royal Society of Chemistry 2017 Electronic Supplementary Information (ESI) for Molecular BioSystems Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE Hyun Uk Kim, Tae Yong Kim and Sang Yup Lee* E-mail: [email protected] Supplementary Table 1. Metabolic reactions of AbyMBEL891 with information on their genes and enzymes. Supplementary Table 2. Metabolites participating in reactions of AbyMBEL891. Supplementary Table 3. Biomass composition of Acinetobacter baumannii. Supplementary Table 4. List of 246 essential reactions predicted under minimal medium with succinate as a sole carbon source. Supplementary Table 5. List of 681 reactions considered for comparison of their essentiality in AbyMBEL891 with those from Acinetobacter baylyi ADP1. Supplementary Table 6. List of 162 essential reactions predicted under arbitrary complex medium. Supplementary Table 7. List of 211 essential metabolites predicted under arbitrary complex medium. AbyMBEL891.sbml Genome-scale metabolic model of Acinetobacter baumannii AYE, AbyMBEL891, is available as a separate file in the format of Systems Biology Markup Language (SBML) version 2. Supplementary Table 1. Metabolic reactions of AbyMBEL891 with information on their genes and enzymes. Highlighed (yellow) reactions indicate that they are not assigned with genes. No. Metabolism EC Number ORF Reaction Enzyme R001 Glycolysis/ Gluconeogenesis 5.1.3.3 ABAYE2829
    [Show full text]
  • THE CAPTIVE MANED WOLF (Chrysocyon Brachyurus
    THE CAPTIVE MANED WOLF ( Chrysocyon brachyurus): NUTRITIONAL CONSIDERATIONS WITH EMPHASIS ON MANAGEMENT OF CYSTINURIA By Sara E. Childs-Sanford Thesis submitted to the Faculty of the Gr aduate School of the University of Maryland, College Park in partial fulfillment of the requirements for the degree of Master of Science 2005 Advisory Committee Dr. Roselina Angel, Chair Dr. Brian Bequette Dr. Joseph Soares Copyright by Sara E. Childs-Sanford 2005 ABSTRACT Title of Thesis: THE CAPTIVE MANED WOLF (Chrysocyon brachyurus) : NUTRITIONAL CONSIDERATIONS WITH EMPHASIS ON MANAGEMENT OF CYSTINURIA Degree Candidate: Sara E. Childs-Sanford Master of Science, 2005 Thesis directed by: Dr. Roselina Angel Department of Animal and Avian Sciences The intent of this project was to investigate options for improvement of a commercially manufactured prescription diet designed to reduce manifestation of clinical disease secondary to cystinuria in captive maned wolves in the United States. Diets high in plant-based protein, independent of sulfur amino acid content, resulted in an increase in average urine pH as well as a decrease in urine cystine crystal formation and cystine excretion in maned wolves. The rate of passage of digesta in maned wolves was very similar to that of domestic dogs on either the commercially available formula and an experimental formula. Differences in nutrient digestibility and mineral retention were seen between the wolves and the dogs, with dogs exhibiting higher digesitibility or retention in all cases. Six maned wolves maintained on these same two diets exhibited plasma taurine concentrations markedly lower than canine and feline normal reference ranges, implying that man ed wolves may have a dietary requirement for taurine.
    [Show full text]